Pros and cons of dabigatran

Am J Health Syst Pharm. 2011 Aug 15;68(16):1495. doi: 10.2146/ajhp110178.
No abstract available

Publication types

  • Editorial
  • Kommentar

MeSH terms

  • Anticoagulants / therapeutic use*
  • Benzimidazoles / therapeutic use*
  • Dabigatran
  • Humans
  • Pyridines / therapeutic use*
  • Thrombin / antagonists & inhibitors*

Substances

  • Anticoagulants
  • Benzimidazoles
  • Pyridines
  • Thrombin
  • Dabigatran